Discover
KZR
Kezar Life Sciences, Inc.
7.29
1 x 7.24
1 x 7.41
bid
ask
+
0.00
0.00%
1 @ 04:00 PM
7.37 +0.08 (1.10%)
| Ytd | 15.90% | |
| 1y | 72.75% |
7.27
day range
7.47
5.20
52 week range
11.40
| Open | 7.36 | Prev Close | 7.29 | Low | 7.27 | High | 7.47 | Mkt Cap | 46.99M |
| Vol | 616.02K | Avg Vol | 108.25K | EPS | -13.12 | P/E | N/A | Forward P/E | -0.62 |
| Beta | 0.22 | Short Ratio | 0.93 | Inst. Own | 63.90% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 7.44 | 200-d Avg | 7.19 | 1yr Est | 13.50 |
| Income Statement | |||
| Operating Expenses | 7.37M | ||
| Research and Development Expense | 1.55M | ||
| Selling, General and Administrative Expense | 5.21M | ||
| Operating Income | -7.36M | ||
| Net Income | -5.76M | ||
| Net Income Common Stock | -5.76M | ||
| Net Income Common Stock (USD) | -5.76M | ||
| Consolidated Income | -5.76M | ||
| Earnings per Basic Share | -0.78 | ||
| Earnings per Basic Share (USD) | -0.78 | ||
| Earnings per Diluted Share | -0.78 | ||
| Earning Before Interest & Taxes (EBIT) | -5.76M | ||
| Earning Before Interest & Taxes (USD) | -5.76M | ||
| Weighted Average Shares | 7.34M | ||
| Weighted Average Shares Diluted | 7.34M | ||
| Balance Sheet | |||
| Cash and Equivalents | 66.23M | ||
| Cash and Equivalents (USD) | 66.23M | ||
| Current Assets | 67.56M | ||
| Property, Plant & Equipment Net | 436.00K | ||
| Total Assets | 68.00M | ||
| Debt Current | 1.35M | ||
| Total Debt | 1.35M | ||
| Current Liabilities | 2.76M | ||
| Total Liabilities | 2.76M | ||
| Accumulated Retained Earnings (Deficit) | -496.29M | ||
| Shareholders Equity | 65.24M | ||
| Shareholders Equity (USD) | 65.24M | ||
| Assets Non-Current | 436.00K | ||
| Total Debt (USD) | 1.35M | ||
| Trade and Non-Trade Payables | 273.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 47.00K | ||
| Net Cash Flow from Financing | 267.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.65M | ||
| Capital Expenditure | 529.00K | ||
| Issuance (Purchase) of Equity Shares | 267.00K | ||
| Net Cash Flow from Investing | 1.53M | ||
| Net Cash Flow from Operations | -7.44M | ||
| Share Based Compensation | 653.00K | ||